Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults . (24th May 2022)
- Record Type:
- Journal Article
- Title:
- Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults . (24th May 2022)
- Main Title:
- Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults
- Authors:
- Shapiro, Janna R
Sitaras, Ioannis
Park, Han Sol
Aytenfisu, Tihitina Y
Caputo, Christopher
Li, Maggie
Lee, John
Johnston, Trevor S
Li, Huifen
Wouters, Camille
Hauk, Pricila
Jacobsen, Henning
Li, Yukang
Abrams, Engle
Yoon, Steve
Kocot, Andrew J
Yang, Tianrui
Huang, Yushu
Cramer, Steven M
Betenbaugh, Michael J
Debes, Amanda K
Morgan, Rosemary
Milstone, Aaron M
Karaba, Andrew H
Pekosz, Andrew
Leng, Sean X
Klein, Sabra L - Abstract:
- Abstract: Background: Male sex and old age are risk factors for severe coronavirus disease 2019, but the intersection of sex and aging on antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has not been characterized. Methods: Plasma samples were collected from older adults (aged 75–98 years) before and after 3 doses of SARS-CoV-2 mRNA vaccination, and from younger adults (aged 18–74 years) post-dose 2, for comparison. Antibody binding to SARS-CoV-2 antigens (spike protein [S], S receptor-binding domain, and nucleocapsid), functional activity against S, and live-virus neutralization were measured against the vaccine virus and the Alpha, Delta, and Omicron variants of concern (VOCs). Results: Vaccination induced greater antibody titers in older females than in older males, with both age and frailty associated with reduced antibody responses in males but not females. Responses declined significantly in the 6 months after the second dose. The third dose restored functional antibody responses and eliminated disparities caused by sex, age, and frailty in older adults. Responses to the VOCs, particularly the Omicron variant, were significantly reduced relative to the vaccine virus, with older males having lower titers to the VOCs than older females. Older adults had lower responses to the vaccine and VOC viruses than younger adults, with greater disparities in males than in females. Conclusions: Older and frail males may be more vulnerableAbstract: Background: Male sex and old age are risk factors for severe coronavirus disease 2019, but the intersection of sex and aging on antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has not been characterized. Methods: Plasma samples were collected from older adults (aged 75–98 years) before and after 3 doses of SARS-CoV-2 mRNA vaccination, and from younger adults (aged 18–74 years) post-dose 2, for comparison. Antibody binding to SARS-CoV-2 antigens (spike protein [S], S receptor-binding domain, and nucleocapsid), functional activity against S, and live-virus neutralization were measured against the vaccine virus and the Alpha, Delta, and Omicron variants of concern (VOCs). Results: Vaccination induced greater antibody titers in older females than in older males, with both age and frailty associated with reduced antibody responses in males but not females. Responses declined significantly in the 6 months after the second dose. The third dose restored functional antibody responses and eliminated disparities caused by sex, age, and frailty in older adults. Responses to the VOCs, particularly the Omicron variant, were significantly reduced relative to the vaccine virus, with older males having lower titers to the VOCs than older females. Older adults had lower responses to the vaccine and VOC viruses than younger adults, with greater disparities in males than in females. Conclusions: Older and frail males may be more vulnerable to breakthrough infections owing to low antibody responses before receipt of a third vaccine dose. Promoting third dose coverage in older adults, especially males, is crucial to protecting this vulnerable population. Abstract : Severe acute respiratory syndrome coronavirus 2 messenger RNA vaccination induces greater antibody response in older females than in older males. Age and frailty reduce responses only in males. These effects are eliminated by a third vaccine dose, highlighting the need for third dose coverage, especially in older males. … (more)
- Is Part Of:
- Clinical infectious diseases. Volume 75(2022)Supplement 1
- Journal:
- Clinical infectious diseases
- Issue:
- Volume 75(2022)Supplement 1
- Issue Display:
- Volume 75, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 75
- Issue:
- 1
- Issue Sort Value:
- 2022-0075-0001-0000
- Page Start:
- S61
- Page End:
- S71
- Publication Date:
- 2022-05-24
- Subjects:
- antibody response -- ACE2 -- sex differences -- Delta -- Omicron -- aging -- frailty
Communicable diseases -- Periodicals
616.905 - Journal URLs:
- http://cid.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.journals.uchicago.edu/CID/journal ↗
http://www.jstor.org/journals/10584838.html ↗ - DOI:
- 10.1093/cid/ciac397 ↗
- Languages:
- English
- ISSNs:
- 1058-4838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.293860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23077.xml